A Novel Therapy for Urinary Tract Infections UTIs are the most common bacterial infections affecting 400 million people per year worldwide, with a treatment market is estimated at $9.89 billion. Up to 80% of UTIs are caused by uropathogenic E. coli that regularly form...
Research in Focus: A Novel Therapy For Urinary Tract Infections As part of #BiofilmWeek, we’re highlighting interesting and exciting biofilm research being undertaken across our NBIC partner research institutions by early career researchers, PhD students and our...
